compound 10 [O'Mahony et al., 2022]   Click here for help

GtoPdb Ligand ID: 11974

PDB Ligand
Compound class: Synthetic organic
Comment: This compound binds to PPARγ without any agonist activity [1]. It inhibits CDK5-mediated phosphorylation of PPARγ at Ser273. Compound 10 was designed for antidiabetic potential, as an alternative to thiazolidinedione class antihyperglycemic PPARγ agonist drugs such as rosiglitazone and pioglitazone.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 81.42
Molecular weight 440.03
XLogP 3.66
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OC(=O)c1nn(Cc2ccc(c(c2)Cl)Cl)c(=O)c2c1ccc(c2)Oc1ccccc1
Isomeric SMILES Clc1cc(Cn2nc(c3ccc(cc3c2=O)Oc2ccccc2)C(=O)O)ccc1Cl
InChI InChI=1S/C22H14Cl2N2O4/c23-18-9-6-13(10-19(18)24)12-26-21(27)17-11-15(30-14-4-2-1-3-5-14)7-8-16(17)20(25-26)22(28)29/h1-11H,12H2,(H,28,29)
InChI Key IQKNCBUBONVBNJ-UHFFFAOYSA-N
Bioactivity Comments
Inhibits phosphorylation of PPARγ Ser273 with IC50 of 160 nM [1].
Selectivity at nuclear hormone receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
Peroxisome proliferator-activated receptor-γ Hs None Binding 7.6 pIC50 - 1
pIC50 7.6 (IC50 2.4x10-8 M) [1]
Description: PPARγ binding